Filing Flows › DarioHealth (DRIO) › Q2 2025
DarioHealth (DRIO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
DarioHealth (DRIO) reported revenue of $5.4M for the second quarter 2025 (Q2 2025), -14% from a year earlier and -20% from the quarter before. Operating margin was -171.4%, net loss $13.0M (241.9% of revenue).
DarioHealth, Q2 2025: revenue $5.4M (-14% year over year), operating margin -171.4%, net loss $13.0M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.4M | -20% | -14% |
| Operating profit | −$9.2M | — | — |
| Net earnings | −$13.0M | — | — |
| Operating cash flow | −$6.0M | — | — |
What changed
Revenue was $5.4M in Q2 2025, down 14% year over year and down 20% from the previous quarter. Services was the largest line at 68% of revenue. Services lost $1.0M year over year (down 21%), 113% of the total change.
Gross margin was 55.2%, up 11.1 points from a year earlier. Operating costs exceeded revenue by $9.2M, an operating margin of -171.4%. Operating expenses fell 36% while revenue fell 14%. The quarter ended with a net loss of $13.0M, wider than the previous quarter's $9.2M loss.
Operating cash flow was −$6.0M. Non-cash charges added back $802K of depreciation and amortization and $2.0M of share-based compensation. Working capital and other items added $4.1M. Capital expenditures of $44K exceeded it, leaving free cash flow of −$6.1M.
Questions
What was DarioHealth's revenue in the second quarter 2025?
DarioHealth (DRIO) reported revenue of $5.4M for the second quarter 2025 (Q2 2025), -14% from a year earlier and -20% from the quarter before.
Was DarioHealth profitable in the second quarter 2025?
Operating loss was $9.2M (-171.4% of revenue) and net loss $13.0M.
Source: DarioHealth 10-Q on SEC EDGAR.